CDC
US federal public health agency; runs HAN advisories, NWSS wastewater surveillance, and ACIP vaccine policy.
Last refreshed: 12 May 2026 · Appears in 1 active topic
Did HAN 00528 signal that Andes hantavirus can spread person-to-person in US hospitals?
Timeline for CDC
B3.13 replicates better in human nasal tissue
Pandemics and BiosecurityMentioned in: Idaho dairy H5N1: 1 to 59 herds in twelve days
Pandemics and BiosecurityCDC mandates airborne isolation for Andes patients
Pandemics and BiosecurityMentioned in: UK airdrops supplies to isolated island Andes case
Pandemics and BiosecurityIssued HAN00528 on 8 May requiring airborne infection isolation for suspected Andes cases and routing US patients to Nebraska biocontainment
Pandemics and Biosecurity: WHO upgrades Hondius Andes risk to MODERATE- What is the CDC Health Alert Network and how does it work?
- The HAN is a tiered communication system issuing alerts, advisories, updates, and information notices to US clinicians and public health officials. HAN 00528 on 8 May 2026 required airborne isolation for Andes hantavirus patients.Source: CDC
- Why did the CDC require airborne precautions for Andes hantavirus in May 2026?
- Andes virus is the only hantavirus with documented person-to-person transmission. HAN 00528 upgraded isolation requirements following the MV Hondius cluster and a confirmed Swiss case, as a precautionary measure ahead of definitive transmission evidence.Source: CDC HAN 00528
- What did the CDC's EID journal find about H5N1 B3.13 in 2026?
- A May 2026 EID paper found that the B3.13 H5N1 clade replicates more efficiently in human nasal tissue than earlier strains, a finding that raised pandemic-risk concern for the ongoing US dairy cattle outbreak.Source: CDC Emerging Infectious Diseases
- How does the CDC's ACIP set vaccine policy in the United States?
- ACIP is an expert advisory committee that meets several times per year to review evidence and vote on immunisation schedule recommendations. Its votes are adopted as policy by HHS and shape clinical practice across US healthcare providers.Source: CDC
Background
The Centers for Disease Control and Prevention (CDC) is the United States' principal federal public health agency, headquartered in Atlanta, Georgia, and operating as a sub-agency of the Department of Health and Human Services. Founded in 1946 as the Communicable Disease Center, it employs roughly 10,000 staff and operates a global network of disease surveillance, laboratory reference capacity, and emergency-response teams. Its core instruments include the Health Alert Network (HAN), which tiers urgent communications to clinicians into alerts, advisories, updates, and information notices; the Morbidity and Mortality Weekly Report (MMWR), the flagship epidemiological journal; and the National Wastewater Surveillance System (NWSS), a community-level early-warning tool launched during the COVID-19 pandemic.
The CDC formulates vaccine policy through the Advisory Committee on Immunisation Practices (ACIP), whose schedules are adopted by most US healthcare providers. It publishes the peer-reviewed journal Emerging Infectious Diseases (EID) and maintains the Emergency Operations Center for outbreak response coordination. The agency's scope spans infectious disease, chronic disease, occupational health, environmental hazards, and injury prevention.
The CDC has faced institutional scrutiny since its widely criticised COVID-19 testing delays in early 2020 and subsequent guidance reversals on masking and school reopening. It underwent a structural reorganisation in 2023 to accelerate outbreak response. In 2026, budget pressures under the second Trump administration raised questions about programme continuity, with ACIP meetings and HAN capacity under review. The agency remains the primary US interface with WHO's International Health Regulations framework.
In the pandemics-and-biosecurity context, the CDC is the source of two significant May 2026 developments. First, HAN 00528, issued 8 May 2026, required airborne infection isolation precautions for all suspected Andes hantavirus patients in US healthcare settings — a precautionary upgrade reflecting the strain's documented person-to-person transmission capacity. Second, the EID journal published a May 2026 paper confirming that the B3.13 H5N1 clade replicates efficiently in human nasal tissue, a finding with direct bearing on pandemic-risk modelling. The CDC also tracks the H5N1 dairy cattle outbreak; the agency's frozen human case counter was cited in coverage of the Idaho H5N1 surge.
